Y-Biologics (XKRX:338840) EPS (Basic) : ₩-1,473.00 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics EPS (Basic)?

Y-Biologics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ₩-110.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,473.00.

Y-Biologics's EPS (Diluted) for the three months ended in Mar. 2024 was ₩-110.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,473.00.

Y-Biologics's EPS without NRI for the three months ended in Mar. 2024 was ₩-109.87. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was -1,478.90.

During the past 3 years, the average EPS without NRI Growth Rate was -8.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Y-Biologics's highest 3-Year average EPS without NRI Growth Rate was 31.00% per year. The lowest was -8.20% per year. And the median was -5.70% per year.

Y-Biologics EPS (Basic) Historical Data

The historical data trend for Y-Biologics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics EPS (Basic) Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Basic)

Get a 7-Day Free Trial

-2,456.00

-1,181.00

-1,005.00

-1,403.00

-1,530.00

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial				-225.00	-160.00	-44.00	-1,159.00	-110.00

Y-Biologics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Y-Biologics's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-18804.401	-	0)	/	12.290
	=	-1,530.06

Y-Biologics's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1623.868	-	0)	/	14.762
	=	-110.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,473.00

Y-Biologics (XKRX:338840) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Y-Biologics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Y-Biologics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines